𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Evaluating the Efficacy of Biosimilar Infliximab with the ACR50 Response in Patients with Rheumatoid Arthritis; A Meta-Analysis in Bayesian Framework

✍ Scribed by Brodszky, V.; Gulacsi, L.; Balogh, O.; V. Hevér, N.; Baji, P.; Péntek, M.

Book ID
122155872
Publisher
John Wiley and Sons
Year
2013
Tongue
English
Weight
61 KB
Volume
16
Category
Article
ISSN
1098-3015

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The safety and efficacy of leflunomide i
The safety and efficacy of leflunomide in combination with infliximab in rheumatoid arthritis
✍ Hansen, K. E. ;Cush, J. ;Singhal, A. ;A. Cooley, D. ;Cohen, S. ;Patel, S. R. ;Ge 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB 👁 2 views

## Objective: To report the safety and efficacy of leflunomide (lef) in combination with infliximab (inf) for the treatment of rheumatoid arthritis. ## Methods: In an open, multicenter, retrospective study, data were collected on the safety and efficacy of lef and inf. ## Results: Eighty-eight

Association of the major histocompatibil
Association of the major histocompatibility complex with response to infliximab therapy in rheumatoid arthritis patients
✍ Alfonso Martinez; Marina Salido; Gema Bonilla; Dora Pascual-Salcedo; Miguel Fern 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB 👁 2 views

## Objective: To determine whether major histocompatibility complex (mhc) polymorphisms are associated with a good or poor response to infliximab therapy in patients with rheumatoid arthritis (ra). ## Methods: Seventy-eight infliximab-treated patients with ra were genotyped for hla-drb1, hla-dqa1